125 related articles for article (PubMed ID: 22416072)
1. Bryostatin analog: improving on Nature's design.
Boger D
Oncotarget; 2012 Feb; 3(2):116-7. PubMed ID: 22416072
[No Abstract] [Full Text] [Related]
2. "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo.
DeChristopher BA; Fan AC; Felsher DW; Wender PA
Oncotarget; 2012 Jan; 3(1):58-66. PubMed ID: 22308267
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review.
Raghuvanshi R; Bharate SB
Curr Top Med Chem; 2020; 20(12):1124-1135. PubMed ID: 32209043
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.
Biberacher V; Decker T; Oelsner M; Wagner M; Bogner C; Schmidt B; Kreitman RJ; Peschel C; Pastan I; Meyer Zum Büschenfelde C; Ringshausen I
Haematologica; 2012 May; 97(5):771-9. PubMed ID: 22180432
[TBL] [Abstract][Full Text] [Related]
5. Modulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.
Grant S
Front Biosci; 1997 Jun; 2():d242-52. PubMed ID: 9195893
[TBL] [Abstract][Full Text] [Related]
6. Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.
Kedei N; Lewin NE; Géczy T; Selezneva J; Braun DC; Chen J; Herrmann MA; Heldman MR; Lim L; Mannan P; Garfield SH; Poudel YB; Cummins TJ; Rudra A; Blumberg PM; Keck GE
ACS Chem Biol; 2013 Apr; 8(4):767-77. PubMed ID: 23369356
[TBL] [Abstract][Full Text] [Related]
7. The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development.
Ruan BF; Zhu HL
Curr Med Chem; 2012; 19(16):2652-64. PubMed ID: 22506770
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.
Kelsey JS; Cataisson C; Chen J; Herrmann MA; Petersen ME; Baumann DO; McGowan KM; Yuspa SH; Keck GE; Blumberg PM
Mol Carcinog; 2016 Dec; 55(12):2183-2195. PubMed ID: 26859836
[TBL] [Abstract][Full Text] [Related]
9. Marine natural products: bryostatins in preclinical and clinical studies.
Kollár P; Rajchard J; Balounová Z; Pazourek J
Pharm Biol; 2014 Feb; 52(2):237-42. PubMed ID: 24033119
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antitumor activity of bryostatins 1, 5, and 8.
Kraft AS; Woodley S; Pettit GR; Gao F; Coll JC; Wagner F
Cancer Chemother Pharmacol; 1996; 37(3):271-8. PubMed ID: 8529289
[TBL] [Abstract][Full Text] [Related]
11. Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged stress and contribute to survival and rejuvenation of human skin equivalents.
Khan TK; Wender PA; Alkon DL
J Cell Physiol; 2018 Feb; 233(2):1523-1534. PubMed ID: 28590053
[TBL] [Abstract][Full Text] [Related]
12. Conversion of high grade lymphoma tumor cell line to intermediate grade with TPA and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis.
al-Katib A; Mohammad RM; Mohamed AN; Pettit GR; Sensenbrenner LL
Hematol Oncol; 1990; 8(2):81-9. PubMed ID: 2344999
[TBL] [Abstract][Full Text] [Related]
13. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
14. Isolation, analytical measurements, and cell line studies of the iron-bryostatin-1 complex.
Plummer S; Manning T; Baker T; McGreggor T; Patel M; Wylie G; Phillips D
Bioorg Med Chem Lett; 2016 May; 26(10):2489-2497. PubMed ID: 27068183
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of bryostatin 1 and phorbol 12-myristate 13-acetate on HOP-92 cell proliferation is mediated by down-regulation of protein kinase Cdelta.
Choi SH; Hyman T; Blumberg PM
Cancer Res; 2006 Jul; 66(14):7261-9. PubMed ID: 16849575
[TBL] [Abstract][Full Text] [Related]
16. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
17. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.
Kedei N; Telek A; Michalowski AM; Kraft MB; Li W; Poudel YB; Rudra A; Petersen ME; Keck GE; Blumberg PM
Biochem Pharmacol; 2013 Feb; 85(3):313-24. PubMed ID: 23146662
[TBL] [Abstract][Full Text] [Related]
18. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
Bouchard C; Lee S; Paulus-Hock V; Loddenkemper C; Eilers M; Schmitt CA
Genes Dev; 2007 Nov; 21(21):2775-87. PubMed ID: 17974917
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic Bryostatin Derivatives from the South China Sea Bryozoan Bugula neritina.
Yu HB; Yang F; Li YY; Gan JH; Jiao WH; Lin HW
J Nat Prod; 2015 May; 78(5):1169-73. PubMed ID: 25932671
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin-5 blocks stromal cell-derived factor-1 induced chemotaxis via desensitization and down-regulation of cell surface CXCR4 receptors.
He X; Fang L; Wang J; Yi Y; Zhang S; Xie X
Cancer Res; 2008 Nov; 68(21):8678-86. PubMed ID: 18974109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]